BioCentury
ARTICLE | Company News

Magainin other research news

March 1, 1999 8:00 AM UTC

MAGN received a $100,000 Phase I SBIR grant from the National Cancer Institute to develop an abbreviated synthetic route for the production of squalamine. The compound, initially isolated from shark l...